Clinical Trial

Tabata Exercise on Nitric Oxide Synthases and Maresin

Completed
View on ClinicalTrials.gov →
Summary
Smoking causes chronic inflammation and endothelial dysfunction through alterations in nitric oxide synthase (NOS) pathways. Maresin is an anti-inflammatory pro-resolving lipid mediator that plays important roles in the resolution of inflammatory processes. Tabata exercise is a short-duration, high-intensity exercise modality with beneficial effects on the cardiovascular system. The aim of this study was to comparatively evaluate the effects of tabata exercise on iNOS, eNOS, and Maresin levels, as well as the relationships among these biomarkers, in smokers and non-smokers.
Trial Details
NCT Number NCT07412639
Lead Sponsor Ataturk University
Conditions Smoking, Smoking, Cigarette
Enrollment 40 participants
Start Date 2025-10-24
Primary Completion 2026-01-16 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-17